CRISPR and Cas Gene Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service, Application, End User, and Geography

Description

List of Tables

The CRISPR and Cas gene market size is expected to grow from US$ 4.13 billion in 2024 to US$ 18.04 billion by 2031; it is projected to register a CAGR of 23.4% during 2025-2031. The rising prevalence of genetic disorders, growing research funding and investments, and surging demand for precision medicine are noteworthy factors contributing to the expansion of the CRISPR and Cas gene market size. Additionally, the evolution toward next-gen editing is projected to bring new CRISPR and Cas gene market trends in the near future.

The CRISPR-Cas gene editing landscape is evolving beyond traditional Cas9 nucleases. Next-generation tools such as base editing, prime editing, and RNA/epigenetic editing offer precision without such risks, driving therapeutic breakthroughs. These techniques can fix 90% of known disease-causing mutations. Base editing, pioneered by David Liu's lab, fuses a deactivated Cas9 with deaminases to convert C*G to T*A or A*T to G*C base pairs. Beam Therapeutics employs base editors to target SCD, achieving up to 80% correction efficiency in hematopoietic stem cells with minimal indels.

Prime editing combines the use of the Cas9 nickase with a reverse transcriptase and a prime editing guide RNA (pegRNA) to enable "search-and-replace" modification, such as insertions and deletions, of a DNA span extending to 44 bp. In 2020, Prime Medicine's technology demonstrated functional correction within patient organoids for the treatment of cystic fibrosis. In February 2025, it carried out first-in-human prime editing in a rare metabolic disorder and showed a modification efficiency ranging between 50%-70%. As of April 2025, there are 98 clinical trials based on these modalities that foretell a new age of safe and versatile gene therapies. The next generation of gene-editing technologies signals a paradigm shift within the CRISPR area. These innovations promise safer, more versatile therapies for genetic diseases, cancer, and infectious disorders, thereby emerging as a significant trend in the CRISPR and Cas gene market.

End User-Based Insights

Based on end user, the CRISPR and Cas gene market is segmented into biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations and CDMOs. The biotechnology and pharmaceutical companies segment held the largest CRISPR and Cas gene market share in 2024. The growth in this segment is driven by their massive investments in clinical development, partnerships, and commercialization to unlock new therapies using CRISPR. One such example is the collaboration between Vertex Pharmaceuticals and CRISPR Therapeutics to create Casgevy (exagamglogene autotemcel), marking the first FDA-approved CRISPR-mediated approach to treating sickle cell disease and transfusion-dependent beta-thalassemia. This approach offers long-term patient benefits by precisely editing hematopoietic stem cells. Similarly, companies like Intellia Therapeutics moved their candidate, NTLA-2002, a CRISPR-based in vivo approach for hereditary angioedema, to a Phase 3 clinical trial in 2025, with encouraging reductions in attack rates. Other examples include Verve Therapeutics and their CTX-310 candidate, which aims to reduce LDL cholesterol and triglycerides by targeting ANGPTL3, with promising phase 1 clinical trial data expected in 2025. This increase in clinical trials and approval highlights that this segment is also witnessing growth driven by their huge requirements for personalized healthcare, increasing incidence rates for genetic disorders, and appropriate acquisition to improve CRISPR technology, making biotech and pharma giants leaders in next-generation gene therapies, thereby fueling the CRISPR and Cas gene market growth.

The World Health Organization and the FDA are among the primary and secondary sources referred to while preparing the CRISPR and Cas gene market report.

Product Code: TIPRE00016686

1. Executive Summary

1.1 Analyst Market Outlook
1.2 Market Attractiveness

2. CRISPR and Cas Gene Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 PEST Analysis
2.5 Impact of Artificial Intelligence (AI)
2.6 Product or Technology Roadmap
2.7 Sustainability and ESG Trends
2.8 Regulatory Framework

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2024 - By Key Players
3.3 Market Concentration

4. CRISPR and Cas Gene Market - Key Industry Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints

5. CRISPR and Cas Gene Market - Global Market Analysis

5.1 CRISPR and Cas Gene Market Revenue (US$ Million), 2021-2031
5.2 CRISPR and Cas Gene Market Forecast and Analysis

6. CRISPR and Cas Gene Market Revenue Analysis -Product And Service

6.1 CRISPR and Cas Gene Market Forecasts and Analysis by Product And Service
- 6.1.1 Product
  - 6.1.1.1 Overview
  - 6.1.1.2 Product: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)
- 6.1.2 Services
  - 6.1.2.1 Overview
  - 6.1.2.2 Services: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)

7. CRISPR and Cas Gene Market Revenue Analysis -Application

7.1 CRISPR and Cas Gene Market Forecasts and Analysis by Application
- 7.1.1 Biomedical
  - 7.1.1.1 Overview
  - 7.1.1.2 Biomedical: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)
- 7.1.2 Agriculture
  - 7.1.2.1 Overview
  - 7.1.2.2 Agriculture: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)

8. CRISPR and Cas Gene Market Revenue Analysis -End User

8.1 CRISPR and Cas Gene Market Forecasts and Analysis by End User
- 8.1.1 Biotechnology and Pharmaceutical Companies
  - 8.1.1.1 Overview
  - 8.1.1.2 Biotechnology and Pharmaceutical Companies: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)
- 8.1.2 Academics and Government Research Institutes
  - 8.1.2.1 Overview
  - 8.1.2.2 Academics and Government Research Institutes: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)
- 8.1.3 Contract Research Organizations (CRO) and CDMOs
  - 8.1.3.1 Overview
  - 8.1.3.2 Contract Research Organizations (CRO) and CDMOs: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)

9. CRISPR and Cas Gene Market - Geographical Analysis

9.1 North America
- 9.1.1 North America CRISPR and Cas Gene Market Overview
- 9.1.2 North America: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 9.1.3 North America: CRISPR and Cas Gene Market- By Segmentation
  - 9.1.3.1 Product And Service
  - 9.1.3.2 Product For Product And Service
  - 9.1.3.3 Services For Product And Service
  - 9.1.3.4 Application
  - 9.1.3.5 Biomedical For Application
  - 9.1.3.6 End User
- 9.1.4 North America: CRISPR and Cas Gene Market Breakdown by Countries
  - 9.1.4.1 United States Market
    - 9.1.4.1.1 United States: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.1.4.1.2 United States: CRISPR and Cas Gene Market- By Segmentation
      - 9.1.4.1.2.1 Product And Service
      - 9.1.4.1.2.2 Product For Product And Service
      - 9.1.4.1.2.3 Services For Product And Service
      - 9.1.4.1.2.4 Application
      - 9.1.4.1.2.5 Biomedical For Application
      - 9.1.4.1.2.6 End User
  - 9.1.4.2 Canada Market
    - 9.1.4.2.1 Canada: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.1.4.2.2 Canada: CRISPR and Cas Gene Market- By Segmentation
      - 9.1.4.2.2.1 Product And Service
      - 9.1.4.2.2.2 Product For Product And Service
      - 9.1.4.2.2.3 Services For Product And Service
      - 9.1.4.2.2.4 Application
      - 9.1.4.2.2.5 Biomedical For Application
      - 9.1.4.2.2.6 End User
  - 9.1.4.3 Mexico Market
    - 9.1.4.3.1 Mexico: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.1.4.3.2 Mexico: CRISPR and Cas Gene Market- By Segmentation
      - 9.1.4.3.2.1 Product And Service
      - 9.1.4.3.2.2 Product For Product And Service
      - 9.1.4.3.2.3 Services For Product And Service
      - 9.1.4.3.2.4 Application
      - 9.1.4.3.2.5 Biomedical For Application
      - 9.1.4.3.2.6 End User
9.2 Europe
- 9.2.1 Europe CRISPR and Cas Gene Market Overview
- 9.2.2 Europe: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 9.2.3 Europe: CRISPR and Cas Gene Market- By Segmentation
  - 9.2.3.1 Product And Service
  - 9.2.3.2 Product For Product And Service
  - 9.2.3.3 Services For Product And Service
  - 9.2.3.4 Application
  - 9.2.3.5 Biomedical For Application
  - 9.2.3.6 End User
- 9.2.4 Europe: CRISPR and Cas Gene Market Breakdown by Countries
  - 9.2.4.1 United Kingdom Market
    - 9.2.4.1.1 United Kingdom: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.2.4.1.2 United Kingdom: CRISPR and Cas Gene Market- By Segmentation
      - 9.2.4.1.2.1 Product And Service
      - 9.2.4.1.2.2 Product For Product And Service
      - 9.2.4.1.2.3 Services For Product And Service
      - 9.2.4.1.2.4 Application
      - 9.2.4.1.2.5 Biomedical For Application
      - 9.2.4.1.2.6 End User
  - 9.2.4.2 Germany Market
    - 9.2.4.2.1 Germany: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.2.4.2.2 Germany: CRISPR and Cas Gene Market- By Segmentation
      - 9.2.4.2.2.1 Product And Service
      - 9.2.4.2.2.2 Product For Product And Service
      - 9.2.4.2.2.3 Services For Product And Service
      - 9.2.4.2.2.4 Application
      - 9.2.4.2.2.5 Biomedical For Application
      - 9.2.4.2.2.6 End User
  - 9.2.4.3 France Market
    - 9.2.4.3.1 France: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.2.4.3.2 France: CRISPR and Cas Gene Market- By Segmentation
      - 9.2.4.3.2.1 Product And Service
      - 9.2.4.3.2.2 Product For Product And Service
      - 9.2.4.3.2.3 Services For Product And Service
      - 9.2.4.3.2.4 Application
      - 9.2.4.3.2.5 Biomedical For Application
      - 9.2.4.3.2.6 End User
  - 9.2.4.4 Italy Market
    - 9.2.4.4.1 Italy: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.2.4.4.2 Italy: CRISPR and Cas Gene Market- By Segmentation
      - 9.2.4.4.2.1 Product And Service
      - 9.2.4.4.2.2 Product For Product And Service
      - 9.2.4.4.2.3 Services For Product And Service
      - 9.2.4.4.2.4 Application
      - 9.2.4.4.2.5 Biomedical For Application
      - 9.2.4.4.2.6 End User
  - 9.2.4.5 Spain Market
    - 9.2.4.5.1 Spain: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.2.4.5.2 Spain: CRISPR and Cas Gene Market- By Segmentation
      - 9.2.4.5.2.1 Product And Service
      - 9.2.4.5.2.2 Product For Product And Service
      - 9.2.4.5.2.3 Services For Product And Service
      - 9.2.4.5.2.4 Application
      - 9.2.4.5.2.5 Biomedical For Application
      - 9.2.4.5.2.6 End User
  - 9.2.4.6 Rest of Europe Market
    - 9.2.4.6.1 Rest of Europe: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.2.4.6.2 Rest of Europe: CRISPR and Cas Gene Market- By Segmentation
      - 9.2.4.6.2.1 Product And Service
      - 9.2.4.6.2.2 Product For Product And Service
      - 9.2.4.6.2.3 Services For Product And Service
      - 9.2.4.6.2.4 Application
      - 9.2.4.6.2.5 Biomedical For Application
      - 9.2.4.6.2.6 End User
9.3 Asia Pacific
- 9.3.1 Asia Pacific CRISPR and Cas Gene Market Overview
- 9.3.2 Asia Pacific: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 9.3.3 Asia Pacific: CRISPR and Cas Gene Market- By Segmentation
  - 9.3.3.1 Product And Service
  - 9.3.3.2 Product For Product And Service
  - 9.3.3.3 Services For Product And Service
  - 9.3.3.4 Application
  - 9.3.3.5 Biomedical For Application
  - 9.3.3.6 End User
- 9.3.4 Asia Pacific: CRISPR and Cas Gene Market Breakdown by Countries
  - 9.3.4.1 China Market
    - 9.3.4.1.1 China: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.3.4.1.2 China: CRISPR and Cas Gene Market- By Segmentation
      - 9.3.4.1.2.1 Product And Service
      - 9.3.4.1.2.2 Product For Product And Service
      - 9.3.4.1.2.3 Services For Product And Service
      - 9.3.4.1.2.4 Application
      - 9.3.4.1.2.5 Biomedical For Application
      - 9.3.4.1.2.6 End User
  - 9.3.4.2 Japan Market
    - 9.3.4.2.1 Japan: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.3.4.2.2 Japan: CRISPR and Cas Gene Market- By Segmentation
      - 9.3.4.2.2.1 Product And Service
      - 9.3.4.2.2.2 Product For Product And Service
      - 9.3.4.2.2.3 Services For Product And Service
      - 9.3.4.2.2.4 Application
      - 9.3.4.2.2.5 Biomedical For Application
      - 9.3.4.2.2.6 End User
  - 9.3.4.3 India Market
    - 9.3.4.3.1 India: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.3.4.3.2 India: CRISPR and Cas Gene Market- By Segmentation
      - 9.3.4.3.2.1 Product And Service
      - 9.3.4.3.2.2 Product For Product And Service
      - 9.3.4.3.2.3 Services For Product And Service
      - 9.3.4.3.2.4 Application
      - 9.3.4.3.2.5 Biomedical For Application
      - 9.3.4.3.2.6 End User
  - 9.3.4.4 Australia Market
    - 9.3.4.4.1 Australia: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.3.4.4.2 Australia: CRISPR and Cas Gene Market- By Segmentation
      - 9.3.4.4.2.1 Product And Service
      - 9.3.4.4.2.2 Product For Product And Service
      - 9.3.4.4.2.3 Services For Product And Service
      - 9.3.4.4.2.4 Application
      - 9.3.4.4.2.5 Biomedical For Application
      - 9.3.4.4.2.6 End User
  - 9.3.4.5 South Korea Market
    - 9.3.4.5.1 South Korea: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.3.4.5.2 South Korea: CRISPR and Cas Gene Market- By Segmentation
      - 9.3.4.5.2.1 Product And Service
      - 9.3.4.5.2.2 Product For Product And Service
      - 9.3.4.5.2.3 Services For Product And Service
      - 9.3.4.5.2.4 Application
      - 9.3.4.5.2.5 Biomedical For Application
      - 9.3.4.5.2.6 End User
  - 9.3.4.6 Rest of APAC Market
    - 9.3.4.6.1 Rest of APAC: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.3.4.6.2 Rest of APAC: CRISPR and Cas Gene Market- By Segmentation
      - 9.3.4.6.2.1 Product And Service
      - 9.3.4.6.2.2 Product For Product And Service
      - 9.3.4.6.2.3 Services For Product And Service
      - 9.3.4.6.2.4 Application
      - 9.3.4.6.2.5 Biomedical For Application
      - 9.3.4.6.2.6 End User
9.4 Middle East and Africa
- 9.4.1 Middle East and Africa CRISPR and Cas Gene Market Overview
- 9.4.2 Middle East and Africa: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 9.4.3 Middle East and Africa: CRISPR and Cas Gene Market- By Segmentation
  - 9.4.3.1 Product And Service
  - 9.4.3.2 Product For Product And Service
  - 9.4.3.3 Services For Product And Service
  - 9.4.3.4 Application
  - 9.4.3.5 Biomedical For Application
  - 9.4.3.6 End User
- 9.4.4 Middle East and Africa: CRISPR and Cas Gene Market Breakdown by Countries
  - 9.4.4.1 Saudi Arabia Market
    - 9.4.4.1.1 Saudi Arabia: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.4.4.1.2 Saudi Arabia: CRISPR and Cas Gene Market- By Segmentation
      - 9.4.4.1.2.1 Product And Service
      - 9.4.4.1.2.2 Product For Product And Service
      - 9.4.4.1.2.3 Services For Product And Service
      - 9.4.4.1.2.4 Application
      - 9.4.4.1.2.5 Biomedical For Application
      - 9.4.4.1.2.6 End User
  - 9.4.4.2 South Africa Market
    - 9.4.4.2.1 South Africa: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.4.4.2.2 South Africa: CRISPR and Cas Gene Market- By Segmentation
      - 9.4.4.2.2.1 Product And Service
      - 9.4.4.2.2.2 Product For Product And Service
      - 9.4.4.2.2.3 Services For Product And Service
      - 9.4.4.2.2.4 Application
      - 9.4.4.2.2.5 Biomedical For Application
      - 9.4.4.2.2.6 End User
  - 9.4.4.3 United Arab Emirates Market
    - 9.4.4.3.1 United Arab Emirates: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.4.4.3.2 United Arab Emirates: CRISPR and Cas Gene Market- By Segmentation
      - 9.4.4.3.2.1 Product And Service
      - 9.4.4.3.2.2 Product For Product And Service
      - 9.4.4.3.2.3 Services For Product And Service
      - 9.4.4.3.2.4 Application
      - 9.4.4.3.2.5 Biomedical For Application
      - 9.4.4.3.2.6 End User
  - 9.4.4.4 Rest of Middle East and Africa Market
    - 9.4.4.4.1 Rest of Middle East and Africa: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.4.4.4.2 Rest of Middle East and Africa: CRISPR and Cas Gene Market- By Segmentation
      - 9.4.4.4.2.1 Product And Service
      - 9.4.4.4.2.2 Product For Product And Service
      - 9.4.4.4.2.3 Services For Product And Service
      - 9.4.4.4.2.4 Application
      - 9.4.4.4.2.5 Biomedical For Application
      - 9.4.4.4.2.6 End User
9.5 South and Central America
- 9.5.1 South and Central America CRISPR and Cas Gene Market Overview
- 9.5.2 South and Central America: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
- 9.5.3 South and Central America: CRISPR and Cas Gene Market- By Segmentation
  - 9.5.3.1 Product And Service
  - 9.5.3.2 Product For Product And Service
  - 9.5.3.3 Services For Product And Service
  - 9.5.3.4 Application
  - 9.5.3.5 Biomedical For Application
  - 9.5.3.6 End User
- 9.5.4 South and Central America: CRISPR and Cas Gene Market Breakdown by Countries
  - 9.5.4.1 Brazil Market
    - 9.5.4.1.1 Brazil: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.5.4.1.2 Brazil: CRISPR and Cas Gene Market- By Segmentation
      - 9.5.4.1.2.1 Product And Service
      - 9.5.4.1.2.2 Product For Product And Service
      - 9.5.4.1.2.3 Services For Product And Service
      - 9.5.4.1.2.4 Application
      - 9.5.4.1.2.5 Biomedical For Application
      - 9.5.4.1.2.6 End User
  - 9.5.4.2 Argentina Market
    - 9.5.4.2.1 Argentina: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.5.4.2.2 Argentina: CRISPR and Cas Gene Market- By Segmentation
      - 9.5.4.2.2.1 Product And Service
      - 9.5.4.2.2.2 Product For Product And Service
      - 9.5.4.2.2.3 Services For Product And Service
      - 9.5.4.2.2.4 Application
      - 9.5.4.2.2.5 Biomedical For Application
      - 9.5.4.2.2.6 End User
  - 9.5.4.3 Rest of South and Central America Market
    - 9.5.4.3.1 Rest of South and Central America: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    - 9.5.4.3.2 Rest of South and Central America: CRISPR and Cas Gene Market- By Segmentation
      - 9.5.4.3.2.1 Product And Service
      - 9.5.4.3.2.2 Product For Product And Service
      - 9.5.4.3.2.3 Services For Product And Service
      - 9.5.4.3.2.4 Application
      - 9.5.4.3.2.5 Biomedical For Application
      - 9.5.4.3.2.6 End User

10. CRISPR and Cas Gene Market Industry Landscape

11. CRISPR and Cas Gene Market - Key Company Profiles

11.1 CRISPR Therapeutics
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Horizon Discovery Group plc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Thermo Fisher Scientific Inc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Merck KGaA
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Integrated DNA Technologies Inc.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 QIAGEN NV
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Takara Bio Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Synthego Holdings LLC
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 GenScript Biotech Corporation
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Editas Medicine Inc
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. List of Additional Companies Analyzed

12.1 List of Additional Companies Analyzed

13. Appendix

13.1 Glossary
13.2 Research Methodology and Approach
- 13.2.1 Secondary Research
- 13.2.2 Primary Research
- 13.2.3 Market Estimation Approach
  - 13.2.3.1 Supply Side Analysis
  - 13.2.3.2 Demand Side Analysis
- 13.2.4 Research Assumptions and Limitations
- 13.2.5 Currency Conversion
13.3 About The Insight Partners
13.4 Market Intelligence Cloud